Literature DB >> 22695896

[Rheumatic diseases during pregnancy].

R Fischer-Betz1.   

Abstract

The treatment of inflammatory rheumatic diseases, such as rheumatoid arthritis, spondylitis ankylosans and systemic lupus erythematosus, is improving continuously. This has lead to an increasing number of young patients with a wish to have children. Greater insight into the course of rheumatic diseases during pregnancy and post partum has enabled optimized support for women with rheumatic diseases wishing to have children. To ensure a favorable outcome, pregnancy should be started during a period of disease stability and should be monitored closely. A careful assessment of possible risks and the justified use of antirheumatic drugs before, during and after pregnancy are key issues for success.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695896     DOI: 10.1007/s00108-012-3029-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  27 in total

1.  Lupus nephritis and pregnancy in the 21st century.

Authors:  Clara J Day; Graham W Lipkin; Caroline O S Savage
Journal:  Nephrol Dial Transplant       Date:  2008-11-26       Impact factor: 5.992

2.  Effect of pregnancy on ankylosing spondylitis: a case-control study.

Authors:  Nai Lee Lui; Nigil Haroon; Adele Carty; Hua Shen; Richard J Cook; Sutha Shanmugarajah; Dafna D Gladman; Robert D Inman
Journal:  J Rheumatol       Date:  2011-08-15       Impact factor: 4.666

Review 3.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis.

Authors:  Andrew Smyth; Guilherme H M Oliveira; Brian D Lahr; Kent R Bailey; Suzanne M Norby; Vesna D Garovic
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

4.  Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience.

Authors:  M Petri; D Howard; J Repke
Journal:  Arthritis Rheum       Date:  1991-12

5.  Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus.

Authors:  Eliza F Chakravarty; Iris Colón; Elizabeth S Langen; David A Nix; Yasser Y El-Sayed; Mark C Genovese; Maurice L Druzin
Journal:  Am J Obstet Gynecol       Date:  2005-06       Impact factor: 8.661

6.  The impact of increased lupus activity on obstetric outcomes.

Authors:  Megan E B Clowse; Laurence S Magder; Frank Witter; Michelle Petri
Journal:  Arthritis Rheum       Date:  2005-02

7.  Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry.

Authors:  M Wallenius; J F Skomsvoll; L M Irgens; K A Salvesen; W Koldingsnes; K Mikkelsen; C Kaufmann; T K Kvien
Journal:  Ann Rheum Dis       Date:  2009-08-27       Impact factor: 19.103

8.  Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome.

Authors:  K Bramham; B J Hunt; S Germain; I Calatayud; M Khamashta; S Bewley; C Nelson-Piercy
Journal:  Lupus       Date:  2009-11-06       Impact factor: 2.911

9.  A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments.

Authors:  M Østensen; L Fuhrer; R Mathieu; M Seitz; P M Villiger
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 10.  Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.

Authors:  Lisa M Askie; Lelia Duley; David J Henderson-Smart; Lesley A Stewart
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

View more
  1 in total

Review 1.  The Diagnosis and Treatment of Systemic Lupus Erythematosus.

Authors:  Annegret Kuhn; Gisela Bonsmann; Hans-Joachim Anders; Peter Herzer; Klaus Tenbrock; Matthias Schneider
Journal:  Dtsch Arztebl Int       Date:  2015-06-19       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.